Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous lidocaine for prevention of postoperative delirium after laparoscopic hysterectomy in older adults
ChiCTR2600120675Phase 4Completed
- Sponsor
- Mianyang Central Hospital
- Start
- Mar 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in postoperative delirium (POD) comparing Lidocaine arm with Control arm (normal saline placebo) (2 arms). Primary endpoint: Cumulative incidence of postoperative delirium within 7 days postoperatively. Started Mar 2026; status: completed.
02
Drugs
lidocaine
03
Conditions
postoperative delirium (POD)
Beyond the preview
Go deeper on ChiCTR2600120675.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600120675.